ºñÁê¾ó
Publications

Research Papers

°Ô½ÃÆÇ º¸±â
ÀÛ¼ºÀÚ ÀÛ¼ºÀÚ°ü¸®ÀÚ
³¯Â¥ 2023-07-28 10:56:16
Á¦¸ñ Validation of the Korean Version of the Community Assessment of Psychic Experiences in General Population.
±â»ç ¸µÅ© http://www.psychiatryinvestigation.org/upload/pdf/pi-2023-0011.pdf
Validation_of_the_Korean_Version_of_the_Community_Assessment_of_Psychic_Experiences_in_General_Population..JPG

Abstract

Objective: The Community Assessment of Psychic Experiences has been widely translated and commonly used as a measure for psychotic experiences and psychosis proneness in clinical and research environments worldwide. This study aimed to establish the psychometric properties (reliability and validity) and factor structure of a Korean version of the Community Assessment of Psychic Experiences (K-CAPE) in the general population.

Methods: A total of 1,467 healthy participants completed K-CAPE and other psychiatric symptom-related scales (Paranoia scale, Patient Health Questionnaire-9, Dissociative Experiences Scale-II, and Oxford-Liverpool Inventory of Feelings and Experiences) via online survey. K-CAPE's internal reliability was analyzed using Cronbach's alpha coefficient. Confirmatory factor analysis (CFA) was performed to investigate whether the original three-factor model (positive, negative, and depressive) and other hypothesized multidimensional models (including positive and negative subfactors) were suitable for our data. Exploratory factor analysis (EFA) was conducted to explore better alternative factor solutions with a follow-up CFA. To assess convergent and discriminant validity, we examined correlations between KCAPE subscales with other established measures of psychiatric symptoms.

Results: K-CAPE showed good internal consistency in all original three subscales (all greater than ¥á=0.827). The CFA demonstrated that the multidimensional models exhibited relatively better quality than the original three-dimensional model. Although the model fit indices did not reach their respective optimal thresholds, they were within an acceptable range. Results from the EFA indicated 3-5 factor solutions. In 3-factor solution, "negative-avolition" items were founded to be loaded more consistently with depressive items than with the negative dimension. In 4-factor solution, positive items were divided into two subfactors: "positive-bizarre experiences" and "positive-delusional thoughts," while negative symptoms were separated into two distinct subfactors in 5-factor solution: "negative-avolition (expressive)," and "negative-social (experiential)." The correlation coefficients between K-CAPE subscales and corresponding measurements were significant (p<0.001), confirming the convergent and discriminant validity.

Conclusion: Our study provides evidence to support the reliability and validity of the K-CAPE and its use as a measure of psychotic symptoms in the Korean population. Although alternative factor structures did not improve the model fit, our EFA findings implicate the use of subfactors to investigate more specific domains of positive and negative symptoms. Given the heterogeneous nature of psychotic symptoms, this may be useful in capturing their different underlying mechanisms.

Keywords: Community assessment of psychic experiences; Prodromal symptoms; Psychosis; Reliability and validity; Validation study.

÷ºÎÆÄÀÏ


ÃÑ °Ô½Ã¹° 54 ÆäÀÌÁö 1/4

   
°Ô½ÃÆÇ ¸®½ºÆ®
¹øÈ£ Á¦¸ñ ÆÄÀÏ ÀÛ¼ºÀÚ ³¯Â¥ Á¶È¸¼ö
54 Associations between post-traumatic stress diso... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.21 175
53 Different topological patterns in structural co... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.18 187
52 Medications for Psychosis: Dopamine Blockers an... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.15 116
ÇöÀç±Û Validation of the Korean Version of the Communi... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.28 108
50 Predictors of full recovery in patients with ea... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.28 201
49 Development of the Korea-Polyenvironmental Risk... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 52
48 The factor structure and clinical utility of cl... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 49
47 Three-year outcomes and predictors for full rec... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 36
46 Associations of Clozapine Use With Psychosocial... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 113
45 DNA Methylation Profiles of the DRD2 and NR3C1 ... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 34
44 Comparison of clinical features and 1-year outc... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 35
43 Clozapine Optimization: A Delphi Consensus Guid... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 79
42 An automatic analysis framework for FDOPA PET n... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.04.18 189
41 Modeling Approach with Therapeutic Drug Monitor... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2022.09.14 219
40 The Relationship Between Frontostriatal Connect... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2022.07.25 224